Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review

EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer

(2011) Nicolas Mottet et al.   EUROPEAN UROLOGY

Is Prophylactic Breast Radiotherapy Necessary in All Patients With Prostate Cancer and Gynecomastia and/or Breast Pain?

(2010) Haluk Ozen et al.   JOURNAL OF UROLOGY

An Open, Randomised, Multicentre, Phase 3 Trial Comparing the Efficacy of Two Tamoxifen Schedules in Preventing Gynaecomastia Induced by Bicalutamide Monotherapy in Prostate Cancer Patients

(2009) Davide Bedognetti et al.   EUROPEAN UROLOGY

A RANDOMIZED TRIAL COMPARING TAMOXIFEN THERAPY VERSUS TAMOXIFEN PROPHYLAXIS IN BICALUTAMIDE INDUCED GYNAECOMASTIA

(2008) Vincenzo Serretta et al.   JOURNAL OF UROLOGY

Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs?

(2008) Carsten Nieder et al.   Radiation Oncology

Die plastische chirurgische Therapie der Gynäkomastie nach antihormoneller Therapie bei Prostatakarzinom

(2008) H. Ryssel et al.   UROLOGE